Summary
- Current Price
- As of today, LAB price is $0.99, down -2.92% on
- Current Price All-Time High
- LAB price is currently -98.00% below its historical high of $49.46 set on
- Market Cap
- LAB current market cap is $381M, down -11.08% year-over-year
- PE Ratio
- LAB PE ratio is unknown
- Revenue
- LAB current annual revenue is $85.33M, down -51.08% year-over-year
- Next Earnings
- The next earnings release for LAB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Standard BioTools Inc. |
| Ticker | NASDAQ: LAB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | standardbio.com |
| Employees | 814 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.99 | |
| Price, 1D Change | -2.92% | |
| $381M | ||
| - | ||
| - | ||
| 1.48 | ||
| $85M | ||
| Revenue, 1Y Change | -51.08% | |
| -$0.20 | ||
| EPS, 1Y Change | +62.50% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | FLDM | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.20 | ||
| EPS Estimate | N/A | -$0.05 |
| EPS Est. Change | N/A | +74.53% |
| $85.33M | ||
| Revenue Estimate | N/A | $81.50M |
| Revenue Est. Change | N/A | -4.49% |
| Current Price | $0.99 | |
| Price Target | - | $1.55 |
| Price Tgt. Change | - | +56.53% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.22 | -$0.52 | -143.44% | |
| -$0.11 | -$0.20 | -78.45% | |
| -$0.05 | N/A | +74.53% | |
| -$0.03 | N/A | +84.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $171.20M | $174.43M | +1.89% | |
| $80.27M | $85.33M | +6.31% | |
| $81.50M | N/A | -4.49% | |
| $83.60M | N/A | -2.03% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.99 | |
| $1.29 | ||
| SMA 200 vs Price | +30.17% | |
| $1.32 | ||
| SMA 50 vs Price | +32.80% | |
| 1.48 | ||
| $0.08 | ||
| 27.30 | ||
| 46.68% | ||
| 68.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $85.33M | ||
| -$0.20 | ||
| $37.12M | ||
| 43.50% | ||
| -$93.31M | ||
| -109.34% | ||
| -$58.83M | ||
| -68.94% | ||
| -$82.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.07 | ||
| 4.19 | ||
| 4.01 | ||
| - | ||
| 2 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.60 | ||
| 0.89 | ||
| -2.48 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $428.58M | ||
| $187.58M | ||
| $567.75M | ||
| $454.26M | ||
| $139.17M | ||
| $108.31M | ||
| $30.83M | ||
| $5.49M | ||
| $5.41M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $144.16M | ||
| $130.42M | ||
| $48.22M | ||
| $0.00 | ||
| $10.98M | ||
| $0.00 | ||
| -$37.88M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$74.35M | ||
| $24.77M | ||
| $570.00K | ||
| $8.30M | ||
| -$82.65M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Keybanc | → | |
| TD Cowen | → | |
| TD Cowen | → | |
| TD Cowen | ||
| Jefferies | ||
| Keybanc | ||
| UBS | ||
| UBS | ||
| Janney Montgomery Scott | → |
Analyst sentiment
Institutional ownership
Screeners with LAB
FAQ
What is the ticker symbol for Standard BioTools Inc.?
The ticker symbol for Standard BioTools Inc. is NASDAQ:LAB
Does Standard BioTools Inc. pay dividends?
No, Standard BioTools Inc. does not pay dividends
What sector is Standard BioTools Inc. in?
Standard BioTools Inc. is in the Healthcare sector
What industry is Standard BioTools Inc. in?
Standard BioTools Inc. is in the Medical Devices industry
What country is Standard BioTools Inc. based in?
Standard BioTools Inc. is headquartered in United States
When did Standard BioTools Inc. go public?
Standard BioTools Inc. initial public offering (IPO) was on February 10, 2011
Is Standard BioTools Inc. in the S&P 500?
No, Standard BioTools Inc. is not included in the S&P 500 index
Is Standard BioTools Inc. in the NASDAQ 100?
No, Standard BioTools Inc. is not included in the NASDAQ 100 index
Is Standard BioTools Inc. in the Dow Jones?
No, Standard BioTools Inc. is not included in the Dow Jones index
When was Standard BioTools Inc. last earnings report?
Standard BioTools Inc.'s most recent earnings report was on February 24, 2026
When does Standard BioTools Inc. report earnings?
The next expected earnings date for Standard BioTools Inc. is May 5, 2026
Data Sources & References
- LAB Official Website www.standardbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1162194/000119312526067026/0001193125-26-067026-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1162194/000119312526067026/0001193125-26-067026-index.htm
- LAB Profile on Yahoo Finance finance.yahoo.com/quote/LAB
- LAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lab